文献速递血栓与止血

肝素诱导的血小板减少症并发体外膜氧合支持:文献综述与替代抗凝选择

Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants.
PubMed 文献 · J Thromb Haemost · 2019-08-04

肝素诱导的血小板减少症(HIT)是肝素类药物的免疫介导并发症,以血小板减少和血栓风险为特征。体外膜氧合(ECMO)患者需持续肝素抗凝以维持回路通畅,HIT风险与肝素累积剂量相关,并发HIT时血栓发生率和死亡率高。本文综述ECMO患者并发HIT的现有认识及替代抗凝选择。

要点

  • HIT是肝素类药物的免疫介导并发症,以中等程度血小板减少和血栓风险增加为特征。
  • ECMO患者持续输注肝素维持回路通畅,HIT风险不可忽视,需在合适临床和实验室情况下纳入鉴别诊断。
  • HIT风险与肝素累积暴露剂量相关。

核心结论

  • ECMO患者接受持续肝素输注时HIT风险不可忽视,在合适的临床和实验室条件下必须将HIT纳入鉴别诊断。

研究设计与样本

  • 本文为文献综述,回顾ECMO患者并发HIT的现有知识及HIT存在时的替代抗凝选择。

主要发现

  • HIT是普通肝素和低分子量肝素治疗的一种危及生命的促血栓、免疫介导并发症。
  • HIT特征为初次肝素暴露后5-10天出现中等程度血小板减少、检测到血小板活化抗血小板因子4/肝素抗体及静脉和动脉血栓风险增加。
  • ECMO患者中HIT与高血栓发病率和死亡率相关。
  • HIT风险与肝素暴露的累积剂量相关。

关键数值与推荐

  • HIT特征为初次肝素暴露后5-10天出现中等程度血小板减少。

临床怎么用

  • ECMO患者持续输注肝素维持回路通畅时,应在合适的临床和实验室情况下将HIT纳入鉴别诊断。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a life-threatening prothrombotic, immune-mediated complication of unfractionated heparin and low molecular weight heparin therapy. HIT is characterized by moderate thrombocytopenia 5-10 days after initial heparin exposure, detection of platelet-activating anti-platelet factor 4/heparin antibodies and an increased risk of venous and arterial thrombosis. Extracorporeal membrane oxygenation (ECMO) is a form of mechanical circulatory support used in critically ill patients with respiratory or cardiac failure. Systemic anticoagulation is used to alleviate the thrombotic complications that may occur when blood is exposed to artificial surfaces within the ECMO circuit. Therefore, when HIT complicates patients on ECMO support, it is associated with a high thrombotic morbidity and mortality. The risk for HIT correlates with the accumulative dosage of heparin exposure. In ECMO patients receiving continuous infusion of heparin for circuit patency, the risk for HIT is not neglected and must be thought of in the differential diagnosis of the appropriate clinical and laboratory circumstances. The following article reviews the current knowledge in HIT complicating ECMO patients and the alternative anticoagulation options in the presence of HIT.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Pollak U. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants. J Thromb Haemost. 2019. PMID: 31313454. doi:10.1111/jth.14575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。